ClinicalTrials.Veeva

Menu

Investigation of Biomarkers in Susac Syndrome

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Unknown

Conditions

Susac Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT01273792
Biomarkers Susac Syndrome

Details and patient eligibility

About

Susac Syndrome is a rare disease and the establishment of the diagnosis is often difficult. The aim of this investigation is to identify relevant biomarkers and to elucidate the pathogenesis of Susac syndrome

Full description

Susac Syndrome is a rare disease characterized by encephalopathy, branch retinal artery occlusion and sensorineural deafness. The pathogenesis is not yet clear, an autoimmune endotheliopathy is discussed. Because of the variable and often incomplete clinical presentation, the establishment of the diagnosis is often delayed or even completely missed.

The aim of this study is to identify biomarkers that facilitate the reliable and prompt establishment of the diagnosis. Patients with a definite diagnosis of Susac syndrome and healthy subjects as controls are investigated.

Furthermore, the correlation of serological markers with structural retinal and cerebral changes will contribute to clarification of the pathogenesis of Susac syndrome.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • adult male and female patients with definite Susac syndrome or matching healthy control subjects
  • ability to provide informed consent

Exclusion criteria

  • pregnancy

Trial design

30 participants in 2 patient groups

Patients with Susac syndrome
Matched healthy controls

Trial contacts and locations

1

Loading...

Central trial contact

Jan M Dörr, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems